Home

DAVID JONATHAN BARRETT

CIK 1359072 · See Remarks · last filed 2017-03-31

DAVID JONATHAN BARRETT is a corporate insider who has filed 18 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ASMB, was dated Mar 31, 2017. Current disclosed insider exposure totals $38.3K across reported positions. 5 SEC filings were submitted jointly with Fortress Biotech, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$38.3K

Companies

4

Total Filings

18

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
ONE PENN PLAZA
SUITE 2514
NEW YORK, NY 10119
Related Filers
Fortress Biotech, Inc. — 5 joint filings, latest 2014-02-24
LUMINUS MANAGEMENT LLC — 2 joint filings, latest 2019-08-05
Luminus Energy Partners Master Fund, Ltd. — 2 joint filings, latest 2019-08-05
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ASMB See Remarks 1,616 $23.67 $38.3K $0 3 2017-03-31
ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted Chief Financial Officer 9,396 — — $0 6 2014-07-14
Fortress Biotech, Inc. (CNDO) Delisted Director 50,000 — — $0 4 2014-02-24
Neuro-Hitech, Inc. (NHPI) Delisted Chief Financial Officer 50,000 — — $0 3 2007-12-11

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-03-31 ASMB Grant (A) — $0 EDGAR
2015-04-15 ASMB Grant (A) +10,000 $0 EDGAR
2014-10-07 ASMB Grant (A) — $0 EDGAR
2014-07-14 ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted Mixed — $0 EDGAR
2014-03-13 ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted Grant (A) — $0 EDGAR
2014-03-12 ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted Grant (A) — $0 EDGAR
2014-02-24 Fortress Biotech, Inc. (CNDO) Delisted Grant (A) +50,000 $0 EDGAR
2013-12-23 Fortress Biotech, Inc. (CNDO) Delisted Grant (A) — $0 EDGAR
2013-04-09 ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted Grant (A) — $0 EDGAR
2013-02-11 Fortress Biotech, Inc. (CNDO) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.